Nuvilex is Beneficiary of Doctors’ Approach Toward Medical Marijuana

A recent poll published in the May 30, 2013 edition of The New England Journal of Medicine shows that fully 76% of poll participants (the poll results include some doctors from outside the U.S) are in favor of the use of marijuana for medicinal purposes.

Read more...
 
PLANDAI’S PRODUCTS MAY INHIBIT PROSTATE CANCER GROWTH

Recent prostate cancer studies involving the use of green tea as a method of inhibiting prostate cancer growth demonstrate yet another major clinical market opportunity for Plandaí Biotechnology Inc. (OTCQB – PLPL - $0.54 – Spec Buy)

Read more...
 
Rare Performance Bolsters Nuvilex’s Approval Prospects

The rare combination of large early stage investments in its pancreatic cancer R&D program and its Phase II clinical trial performance strongly bolsters Nuvilex’s (OTCQB – NVLX) prospects for approval of its treatment for advanced inoperable pancreatic cancer.

Read more...
 
A Niche E&P with Huge Potential

Today we are initiating coverage of Multi-Corp International Inc. (OTCPK – MULI). There is the potential for some really good news on Tuesday so read carefully lest that point slip by you. Now, if the news is neutral or bad the shares would go south but we are betting it will be good, rather than neutral or bad. The bottom line is that we introduced you to NORX on Monday at $0.94 and it hit $2.06 earlier this week. This is another really unconventional junior E&P story that has long term potential if things go their way, in addition to the trading aspect alluded to above.

Read more...
 
PLPL: PLANDAI BENEFITS FROM INDUSTRY’S EGCG ALZHEIMER STUDIES

According to a recent study published in the Journal of Biology Chemistry, Epigallocatechin gallate (EGCG), the most abundant catechin found in green tea, has demonstrated the ability to serve as a treatment for Alzheimer’s disease.

Read more...
 
NVLX: Low Level of Toxicity a Major Plus for Nuvilex’

As Nuvilex Inc. (QTCQB - NVLX - $0.14 - Spec Buy) management can attest, scientists and clinicians often approach drug development and treatment very differently.

Read more...
 
Plandai Products to Assist in Weight Management

While a great deal of attention has been focused on the treatment and prevention of major diseases such as malaria and other conditions using key green tea extracts such as Epigallocatechin gallate (EGCG)

Read more...
 
Nuvilex Could Help Shape Future of Medical Marijuana

On the heels of the latest Barron's cover story, marijuana use is a topic that will continue to gain fans and ultimately approval.

Read more...
 
NORX: An Overlooked Bakken Play
This undiscovered Bakken play could be hugely profitable next year and double from current prices.
Read more...
 
Powerball Winner Could Benefit from INSCOR’s FIT Plan

While the benefits of FIT OPEB to municipalities have taken center stage, the FIT plan for wealthy and uber-wealthy individuals could be a meaningful profit center for INSCOR

Read more...
 
<< Start < Prev 31 32 33 34 35 36 37 38 39 40 Next > End >>

Page 32 of 40